Rosetta Genomics (NASDAQ: ROSG) Executes Credentialing Agreement with Three Rivers Provider Network; One in Five Americans now Covered for Rosetta Cancer Origin Test
Leading microRNA-based molecular diagnostics developer and provider Rosetta Genomics Ltd. announced it has executed a credentialing agreement with Three Rivers Provider Network, Inc. (TRPN) for the Rosetta Cancer Origin Test. Based in Chula Vista, Calif., TRPN is one of the United States’ largest supplemental preferred provider organizations (PPO), providing healthcare benefits to more than 10 million members throughout the country. This represents the second credentialing agreement that has been executed between Rosetta and a U.S. PPO, which is a managed care organization of medical doctors, hospitals and other healthcare providers that has covenanted to provide healthcare at reduced rates to…